62 results
424B4
APTO
Aptose Biosciences Inc
26 Jan 24
Prospectus supplement with pricing info
5:30pm
as a director or nominee.
Composition and Independence of the Board
Our Board is currently composed of seven directors, a majority (six) of whom meet … the independence standards under the listing standards of Nasdaq, the rules and regulations of the SEC, and NI 52-110. Each year the Board reviews
S-8
EX-4.1
f3yaj i4yci6
21 Sep 23
Registration of securities for employees
5:10pm
424B3
yrgkdiffhbcy35r
6 Jul 23
Prospectus supplement
4:01pm
S-1
wktk8h9 mymf8cgx
16 Jun 23
IPO registration
6:42pm
8-K
EX-10.1
7ts47lxxpjalgdwz9
12 Dec 22
Entry into a Material Definitive Agreement
8:00am
8-K
EX-99.1
gyf8kr gder54d
19 Jul 22
Financial Statements and Exhibits
5:53pm
8-K
EX-99.1
ui2o0ce jvvz
27 Jun 22
Financial Statements and Exhibits
9:55am
8-K
EX-1.1
b8y1z6ooya
16 Jul 20
Aptose Announces Pricing of Public Offering of Common Shares
4:05pm
8-K
EX-10.1
8sx6w 5y4lftmad
5 May 20
Aptose Reports Results for the First Quarter 2020
5:01pm